Page last updated: 2024-08-23

bucindolol and hydrochlorothiazide

bucindolol has been researched along with hydrochlorothiazide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Lehtonen, A; Tanskanen, A; Temmerman, J	1
Fedder, IL; Ferguson, RK; Rocci, ML; Rotmensch, HH; Soyka, L; Swanson, BN; Vlasses, PH	1

Trials

1 trial(s) available for bucindolol and hydrochlorothiazide

Article	Year
Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension. The American journal of cardiology, 1984, Aug-01, Volume: 54, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propanolamines; Renin; Vasodilator Agents	1984

Other Studies

2 other study(ies) available for bucindolol and hydrochlorothiazide

Article	Year
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients. International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:8 Topics: Adrenergic beta-Antagonists; Adult; Aged; Cholesterol; Cholesterol, HDL; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Propanolamines; Triglycerides	1987

Article

Year

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008

Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.

International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:8

Topics: Adrenergic beta-Antagonists; Adult; Aged; Cholesterol; Cholesterol, HDL; Female; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Propanolamines; Triglycerides

1987